As a pioneer cancer research and as the beneficiary of funds
raised by This Close, The Brander Cancer Research Institute (BCRI)
has been a leader in providing innovative protocols that are
used every day at
medical facilities around the world.
Among some of the exciting breakthroughs this year, BCRI has:
1. Developed a method to recognize cells that
undergo apoptosis based on the DNA damage in these cells.
2. Developed an entirely
new type of reagent that detects the activation of
proteolytic enzymes called caspases.
3. Developed a new approach to protect people
from the harmful side effects of chemotherapy.
4. Testing a new drug called ONCONASE for use in
5. Made significant studies
of the antitumor herbal drug called PC-SPES.